The startup develops a protein engineering platform that utilizes molecular biology and computational methods to create high-performance enzymes. These enzymes address challenges in diagnostics, life sciences, manufacturing, pharmaceuticals, and food ingredients, enabling clients to enhance their biological research capabilities.
Funding
$790K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many industries face challenges in optimizing biological processes due to limitations in existing enzyme performance, stability, and specificity. Traditional enzyme development methods are often slow, costly, and unable to address complex industrial needs effectively.
Solution
Entropix leverages directed evolution and computational biology to engineer high-performance enzymes tailored for specific applications. Their protein engineering platform combines experimental molecular technology, algorithmic computation, and machine learning to accelerate the natural process of enzyme evolution. By analyzing genetic variations and enzyme structures, Entropix identifies connections between amino acid sequences and enzyme function, enabling the creation of novel biocatalysts with enhanced resilience and performance. This approach allows for the rapid development of enzymes that can transform processes across diagnostics, life sciences, manufacturing, pharmaceuticals, and food ingredients. Entropix also offers a novel technology for nucleic acid purification called NADA™, which provides rapid, efficient, and solvent-free purification of DNA and RNA.
Target Audience
Entropix serves companies in diagnostics, life sciences, manufacturing, pharmaceuticals, and food ingredients seeking to enhance their biological research and industrial processes through optimized enzyme solutions.
Features
- Directed evolution platform for generating novel enzymes with tailored characteristics
- Computational gene sequence analysis and enzyme structure analysis
- Machine learning algorithms to predict patterns of enzyme evolution
- High-throughput screening assays for identifying variants with desired phenotypes
- Proprietary NADA™ technology for rapid and efficient nucleic acid purification
- Capabilities for gene sequencing, analysis, and design
- High-yield, tunable mutagenesis for creating diverse enzyme libraries
- Protein expression, purification, and quantification services